Specialty Pharma Journal Specialty, Precision & Technology
CARLSBAD, Calif., Sept. 18, 2018 /PRNewswire/ — Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio. Under the terms of the licenses, Thermo Fisher …
Tag Archives: ERS Genomics
September, 2018
May, 2016
-
17 May
Bayer and ERS Genomics Announce Licensing Agreement for Genome-Editing Patents
LEVERKUSEN, Germany & DUBLIN–(BUSINESS WIRE)–Bayer and ERS signed a patent license agreement whereby Bayer gains access to ERS’ CRISPR-Cas9 genome-editing patents for certain cross-divisional applications in Bayer’s core strategic areas. ERS Genomics holds rights to the foundational CRISPR-Cas9 patent portfolio from Dr. Emmanuelle Charpentier, an inventor of the breakthrough gene-editing …